Mobia Medical, Inc. Common Stock
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $379.7M
- Price
- $11.42
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.64%
- Volume
- 115.0K
About
Mobia Medical, Inc. functions as a commercial-level medical device enterprise, concentrating on developing therapeutic solutions for individuals recovering from strokes who experience motor impairments. The company was established on March 5, 2007, by its founders Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini, and it maintains its corporate headquarters in Austin, Texas.
Quick stats
Shares outstanding33.2M
Computed float19.0M
Float / shares57.1%
Cash runway (months)4.8
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001489993
Websitehttps://www.mobia.com
AI Summary
AI-generated1/12
majorbullishearnings
Mobia Medical Reports Second Quarter 2026 Financial Results
Mobia Medical reported Q2 2026 revenue of $13.5 million, up 102% year-over-year, driven by higher adoption of the Vivistim System. Gross margin remained strong at 83.2%, while net loss widened to $21.0 million due to increased commercial and development spending.
The company closed its initial public offering in May 2026, raising approximately $134.0 million in net proceeds and ending the quarter with $177.1 million in cash.
Management raised full-year 2026 revenue guidance to a range of $54.0 million to $56.0 million, representing expected growth of 69% to 75% over the prior year.
Red flags
- Operating expenses increased 83% year-over-year to $29.2 million, outpacing revenue growth and widening the net loss.